...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ,Hong Kong exchange
Reply New Message
Prev Message Back To Forum Threaded View Next Message

KK2/narmac - I still believe it will be easier for management to get a better price for Zenith as a private company than as a public company. Every company can be valued not only on its balance sheet but on the potential of its assets as well.

All IMO

tada

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply